相似文献
1
Pharmacotherapy and airway remodelling in asthma?
Thorax. 2003 Feb;58(2):163-74. doi: 10.1136/thorax.58.2.163.
2
The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Exp Mol Med. 2006 Apr 30;38(2):109-18. doi: 10.1038/emm.2006.14.
3
Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.
Adv Ther. 2008 Apr;25(4):342-54. doi: 10.1007/s12325-008-0048-4.
4
[Alternations of bronchial smooth muscle and effect of therapy on remodeling in asthma].
Pol Merkur Lekarski. 2006 Jul;21(121):5-7.
5
Airway wall remodelling: the influence of corticosteroids.
Curr Opin Allergy Clin Immunol. 2005 Feb;5(1):43-8. doi: 10.1097/00130832-200502000-00009.
6
Inhaled steroids and airway remodelling in asthma.
Acta Biomed. 2003 Dec;74(3):121-5.
7
Asthma therapy: effects on airway inflammation and remodelling.
Can Respir J. 1998 Jan-Feb;5(1):68-70.
8
Remodeling in asthma and chronic obstructive lung disease.
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S28-38. doi: 10.1164/ajrccm.164.supplement_2.2106061.
9
Therapeutic interventions aimed at reducing airway smooth muscle growth.
Monaldi Arch Chest Dis. 2000 Aug;55(4):311-6.
10
CD8(+) T cells characterize early smoking-related airway pathology in patients with asthma.
Respir Med. 2013 Jul;107(7):959-66. doi: 10.1016/j.rmed.2013.03.018. Epub 2013 Apr 30.
引用本文的文献
1
Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma.
Respir Res. 2024 Feb 5;25(1):76. doi: 10.1186/s12931-024-02706-4.
2
Pharmacological Properties of 2,4,6-Trihydroxy-3-Geranyl Acetophenone and the Underlying Signaling Pathways: Progress and Prospects.
Front Pharmacol. 2021 Aug 31;12:736339. doi: 10.3389/fphar.2021.736339. eCollection 2021.
3
IL-32γ attenuates airway fibrosis by modulating the integrin-FAK signaling pathway in fibroblasts.
Respir Res. 2018 Sep 26;19(1):188. doi: 10.1186/s12931-018-0863-3.
4
The Variants in the 3' Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma.
Lung. 2018 Jun;196(3):297-303. doi: 10.1007/s00408-018-0113-y. Epub 2018 Mar 29.
5
Airway remodeling in asthma: what really matters.
Cell Tissue Res. 2017 Mar;367(3):551-569. doi: 10.1007/s00441-016-2566-8. Epub 2017 Feb 11.
6
Bronchoconstriction Induces Structural and Functional Airway Alterations in Non-sensitized Rats.
Lung. 2017 Apr;195(2):167-171. doi: 10.1007/s00408-016-9970-4. Epub 2016 Dec 26.
7
Statins in Asthma: Potential Beneficial Effects and Limitations.
Pulm Med. 2015;2015:835204. doi: 10.1155/2015/835204. Epub 2015 Nov 5.
8
Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9.
Arch Immunol Ther Exp (Warsz). 2016 Feb;64(1):47-55. doi: 10.1007/s00005-015-0345-y. Epub 2015 Jun 28.
9
Lost to follow-up in asthmatics does not mean treatment failure: causes and clinical outcomes of non-adherence to outpatient treatment in adult asthma.
Allergy Asthma Immunol Res. 2013 Nov;5(6):357-64. doi: 10.4168/aair.2013.5.6.357. Epub 2013 Sep 27.
10
Central role of cellular senescence in TSLP-induced airway remodeling in asthma.
PLoS One. 2013 Oct 22;8(10):e77795. doi: 10.1371/journal.pone.0077795. eCollection 2013.
本文引用的文献
1
The pathology of asthma, with special reference to changes in the bronchial mucosa.
J Clin Pathol. 1960 Jan;13(1):27-33. doi: 10.1136/jcp.13.1.27.
2
Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory?
Clin Exp Allergy. 2002 Aug;32(8):1124-7. doi: 10.1046/j.1365-2745.2002.01474.x.
3
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness.
Nature. 2002 Jul 25;418(6896):426-30. doi: 10.1038/nature00878. Epub 2002 Jul 10.
4
Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Thorax. 2002 Mar;57(3):237-41. doi: 10.1136/thorax.57.3.237.
5
Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma.
Am J Respir Crit Care Med. 2001 Sep 15;164(6):1047-52. doi: 10.1164/ajrccm.164.6.2010045.
6
Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression.
Eur Respir J. 2001 Jul;18(1):139-45. doi: 10.1183/09031936.01.00067901.
7
Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells.
Eur J Pharmacol. 2001 Aug 10;425(2):109-16. doi: 10.1016/s0014-2999(01)01192-x.
8
Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells.
Eur Respir J. 2001 Jun;17(6):1070-7. doi: 10.1183/09031936.01.00073301.
9
Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma.
Am J Respir Crit Care Med. 2001 Jul 1;164(1):117-21. doi: 10.1164/ajrccm.164.1.2006003.
10
Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma.
Clin Exp Allergy. 2001 May;31(5):722-30. doi: 10.1046/j.1365-2222.2001.01071.x.
Zotero 插件